Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Elisabetta Patorno

Title(s)Adjunct Instructor, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Insights from predicting results of the GRADE trial using real-world data. Diabetes Obes Metab. 2025 Nov; 27(11):6798-6802. Kattinakere Sreedhara S, Schneeweiss S, DiCesare E, Patorno E, Tsacogianis TN, Bradley MC, Wang SV. PMID: 40916234.
      View in: PubMed   Mentions:
    2. Letter to the Editor. Am J Gastroenterol. 2025 Dec 01; 120(12):2984-2985. Cromer SJ, Alkabbani W, Patorno E. PMID: 40838998.
      View in: PubMed   Mentions:
    3. APPRAISE: A Tool for Appraising Potential for Bias in Real-World Evidence Studies on Medication Effectiveness or Safety. Value Health. 2025 Dec; 28(12):1849-1856. Bykov K, Jaksa A, Lund JL, Franklin JM, Girman CJ, Gazarian M, Yuan H, Duffield S, Kent S, Patorno E. PMID: 40774597; PMCID: PMC12392756.
      View in: PubMed   Mentions:
    4. Overall Uptake and Racial, Ethnic, and Socioeconomic Disparities in the Use of Continuous Glucose Monitoring Devices Among Insulin-Treated Older Adults With Type 2 Diabetes. Diabetes Care. 2025 Aug 01; 48(8):1377-1385. Alkabbani W, Cromer SJ, Kim DH, Paik JM, Bykov K, Munshi M, Wexler DJ, Patorno E. PMID: 40445849; PMCID: PMC12718080.
      View in: PubMed   Mentions:
    5. Author Correction: Incorporating genetic data improves target trial emulations and informs the use of polygenic scores in randomized controlled trial design. Nat Genet. 2025 Aug; 57(8):2074. German J, Yang Z, Urbut S, Vartiainen P, FinnGen, Natarajan P, Patorno E, Kutalik Z, Philippakis A, Ganna A. PMID: 40579539; PMCID: PMC12339395.
      View in: PubMed   Mentions:
    6. Incorporating genetic data improves target trial emulations and informs the use of polygenic scores in randomized controlled trial design. Nat Genet. 2025 Jul; 57(7):1620-1627. German J, Yang Z, Urbut S, Vartiainen P, FinnGen, Natarajan P, Patorno E, Kutalik Z, Philippakis A, Ganna A. PMID: 40533517; PMCID: PMC12283355.
      View in: PubMed   Mentions:
    7. Treatment modality for aneurysmal subarachnoid hemorrhage and risk of shunt dependent hydrocephalus and mortality: population based study. J Neurointerv Surg. 2025 Jun 16; 17(7):703-710. Omar AT, Diestro JDB, Spears J, Patorno E. PMID: 38839284.
      View in: PubMed   Mentions:
    8. Utilization Trends of Dual GIP/GLP-1 Receptor Agonist, Newer Glucose-Lowering Medications, and Anti-Obesity Medications Among Patients With Chronic Kidney Disease With and Without Type 2 Diabetes. Kidney Med. 2025 Jun; 7(6):101013. Hansrivijit P, Ortega-Montiel J, Wexler DJ, Patorno E, Paik JM. PMID: 40510603; PMCID: PMC12152630.
      View in: PubMed   Mentions:
    9. Trends in Utilization of Glucose- and Weight-Lowering Medications After Tirzepatide Approval in the United States : A Population-Based Cohort Study. Ann Intern Med. 2025 May; 178(5):620-633. Ostrominski JW, Ortega-Montiel J, Tesfaye H, Alix C, DiCesare E, Cromer SJ, Wexler DJ, Paik JM, Patorno E. PMID: 40228298; PMCID: PMC12718076.
      View in: PubMed   Mentions:
    10. Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary Disease Exacerbations in Patients With Type 2 Diabetes. JAMA Intern Med. 2025 Apr 01; 185(4):399-410. Ray A, Paik JM, Wexler DJ, Sreedhara SK, Bykov K, Feldman WB, Patorno E. PMID: 39928303; PMCID: PMC11811870.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Linkage of Clinical Trial Data to Routinely Collected Data Sources: A Scoping Review. JAMA Netw Open. 2025 04 01; 8(4):e257797. NajafZadeh M, Fernández Oromendia A, Burcu M, Mcconnochie B, Kim E, Vaccaro T, Patorno E. PMID: 40299382; PMCID: PMC12042059.
      View in: PubMed   Mentions:
    12. Prescribing Trends of Glucose-Lowering Medications Near End of Life Among Adults With Type 2 Diabetes: A Cohort Study. Diabetes Care. 2025 Mar 01; 48(3):455-463. Kutz A, Kim DH, Liu J, Munshi MN, Patorno E. PMID: 39746144; PMCID: PMC11870286.
      View in: PubMed   Mentions:
    13. Comparative Effectiveness of Individual Sodium-Glucose Cotransporter 2 Inhibitors. JAMA Intern Med. 2025 Mar 01; 185(3):302-313. Shin H, Paik JM, Everett BM, DiCesare E, Alix C, Glynn RJ, Wexler DJ, Patorno E. PMID: 39836397; PMCID: PMC11877166.
      View in: PubMed   Mentions:
    14. Empagliflozin versus DPP4i or GLP-1RA for the risk of nephrolithiasis in patients with type 2 diabetes: Research letter from the EMPRISE cohort study. Diabetes Obes Metab. 2025 Jun; 27(6):3503-3508. Tesfaye H, Paik JM, Zakoul H, Schmedt N, Wexler DJ, Patorno E. PMID: 40019137; PMCID: PMC12049256.
      View in: PubMed   Mentions:
    15. Utilization Trends of Glucose-Lowering Medications Among Adult Kidney Transplant Recipients with Type 2 Diabetes in the United States. J Clin Med. 2025 Jan 20; 14(2). Hansrivijit P, Tesfaye H, Wexler DJ, Abdi R, Patorno E, Paik JM. PMID: 39860655; PMCID: PMC11766230.
      View in: PubMed   Mentions:
    16. Empagliflozin and the Risk of Retinopathy in Patients With Type 2 Diabetes. JAMA Ophthalmol. 2025 Jan 01; 143(1):62-71. Tesfaye H, Paik JM, Roh M, Htoo PT, Zakoul H, Schmedt N, Koeneman L, Wexler DJ, Patorno E. PMID: 39636645; PMCID: PMC11622102.
      View in: PubMed   Mentions:
    17. Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013-2019. Diabetologia. 2025 Jan; 68(1):94-104. Wang E, Patorno E, Khosrow-Khavar F, Crystal S, Dave CV. PMID: 39514094; PMCID: PMC11663158.
      View in: PubMed   Mentions:
    18. Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes. Diabetes Care. 2024 Nov 01; 47(11):1900-1907. Htoo PT, NajafZadeh M, Tesfaye H, Schneeweiss S, Wexler DJ, Glynn RJ, Schmedt N, Déruaz-Luyet A, Koeneman L, Paik JM, Patorno E. PMID: 38917305; PMCID: PMC11502532.
      View in: PubMed   Mentions:
    19. Well-Conducted Real-World Evidence Studies Can Complement Essential Evidence From Clinical Trials. Circulation. 2024 Oct 29; 150(18):1412-1415. Patorno E. PMID: 39466890.
      View in: PubMed   Mentions:
    20. Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study. BMJ. 2024 10 22; 387:e080340. Alkabbani W, Suissa K, Gu KD, Cromer SJ, Paik JM, Bykov K, Hobai I, Thompson CC, Wexler DJ, Patorno E. PMID: 39438043; PMCID: PMC11494456.
      View in: PubMed   Mentions:
    21. Perinatal Outcomes Associated With Metformin Use During Pregnancy in Women With Pregestational Type 2 Diabetes Mellitus. Diabetes Care. 2024 Sep 01; 47(9):1688-1695. Yland JJ, Huybrechts KF, Wesselink AK, Straub L, Chiu YH, Seely EW, Patorno E, Bateman BT, Mogun H, Wise LA, Hernández-Díaz S. PMID: 39042587; PMCID: PMC11362109.
      View in: PubMed   Mentions:
    22. Bariatric surgery and all-cause mortality: A methodological review of studies using a non-surgical comparator. Diabetes Obes Metab. 2024 Oct; 26(10):4273-4280. Suissa K, Schneeweiss S, Glynn RJ, Wexler DJ, Suissa S, Paik JM, Patorno E. PMID: 39014528; PMCID: PMC11800116.
      View in: PubMed   Mentions:
    23. Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Nephrolithiasis in Clinical Practice-Reply. JAMA Intern Med. 2024 Jul 01; 184(7):852-853. Paik JM, Patorno E. PMID: 38805217.
      View in: PubMed   Mentions:
    24. SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study. BMJ. 2024 06 26; 385:e078483. Fu EL, Wexler DJ, Cromer SJ, Bykov K, Paik JM, Patorno E. PMID: 38925801; PMCID: PMC11200155.
      View in: PubMed   Mentions:
    25. Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations: Emulating a Target Trial Using Real-World Data. Ann Intern Med. 2024 Jul; 177(7):862-870. Chiu YH, Huybrechts KF, Patorno E, Yland JJ, Cesta CE, Bateman BT, Seely EW, Hernán MA, Hernández-Díaz S. PMID: 38885505; PMCID: PMC12617958.
      View in: PubMed   Mentions:
    26. Empagliflozin and Risk of Incident Gout: Analysis from the EMPagliflozin Comparative Effectiveness and SafEty (EMPRISE) Cohort Study. J Gen Intern Med. 2024 Aug; 39(10):1870-1879. Tesfaye H, Wang KM, Zabotka LE, Wexler DJ, Schmedt N, Koeneman L, Seman L, Paik JM, Patorno E. PMID: 38710868; PMCID: PMC11282041.
      View in: PubMed   Mentions:
    27. Trends in the Use of Medications for Secondary Ischemic Stroke Prevention in Denmark, 2005-2021. Neurology. 2024 May 14; 102(9):e209309. Skajaa N, Laugesen K, Lauffenburger JC, Schwamm LH, Sørensen HT, Patorno E. PMID: 38648572; PMCID: PMC11226314.
      View in: PubMed   Mentions:
    28. Effectiveness and safety of empagliflozin: final results from the EMPRISE study. Diabetologia. 2024 Jul; 67(7):1328-1342. Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Schmedt N, Koeneman L, Déruaz-Luyet A, Paik JM, Patorno E. PMID: 38509341.
      View in: PubMed   Mentions:
    29. Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study. Cardiovasc Diabetol. 2024 Mar 18; 23(1):103. Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Schmedt N, Koeneman L, Déruaz-Luyet A, Paik JM, Patorno E. PMID: 38500096; PMCID: PMC10949568.
      View in: PubMed   Mentions:
    30. GLP-1 Receptor Agonists and Gastrointestinal Adverse Events. JAMA. 2024 03 12; 331(10):884-885. Suissa K, Cromer SJ, Patorno E. PMID: 38470390.
      View in: PubMed   Mentions:
    31. Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes. JAMA Intern Med. 2024 Mar 01; 184(3):265-274. Paik JM, Tesfaye H, Curhan GC, Zakoul H, Wexler DJ, Patorno E. PMID: 38285598; PMCID: PMC10825784.
      View in: PubMed   Mentions:
    32. Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED): considerations from the FDA Sentinel Innovation Center. BMJ. 2024 02 12; 384:e076460. Desai RJ, Wang SV, Sreedhara SK, Zabotka L, Khosrow-Khavar F, Nelson JC, Shi X, Toh S, Wyss R, Patorno E, Dutcher S, Li J, Lee H, Ball R, Dal Pan G, Segal JB, Suissa S, Rothman KJ, Greenland S, Hernán MA, Heagerty PJ, Schneeweiss S. PMID: 38346815.
      View in: PubMed   Mentions:
    33. Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study. Cardiovasc Diabetol. 2024 02 08; 23(1):57. Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Schmedt N, Koeneman L, Déruaz-Luyet A, Paik JM, Patorno E. PMID: 38331813; PMCID: PMC10854040.
      View in: PubMed   Mentions:
    34. Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy. JAMA Intern Med. 2024 02 01; 184(2):144-152. Cesta CE, Rotem R, Bateman BT, Chodick G, Cohen JM, Furu K, Gissler M, Huybrechts KF, Kjerpeseth LJ, Leinonen MK, Pazzagli L, Zoega H, Seely EW, Patorno E, Hernández-Díaz S. PMID: 38079178; PMCID: PMC10714281.
      View in: PubMed   Mentions:
    35. A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes. Kidney Int. 2024 Mar; 105(3):618-628. Fu EL, Mastrorilli J, Bykov K, Wexler DJ, Cervone A, Lin KJ, Patorno E, Paik JM. PMID: 38101515; PMCID: PMC10922914.
      View in: PubMed   Mentions:
    36. Risk of Severe Hypoglycemia With Newer Second-line Glucose-lowering Medications in Older Adults With Type 2 Diabetes Stratified by Known Indicators of Hypoglycemia Risk. J Gerontol A Biol Sci Med Sci. 2023 12 01; 78(12):2426-2434. Htoo PT, Paik JM, Alt E, Kim DH, Wexler DJ, Kim SC, Patorno E. PMID: 36866496; PMCID: PMC10692415.
      View in: PubMed   Mentions:
    37. Successful implementation of a stakeholder engagement program for pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 2024 01; 33(1):e5727. Cromer SJ, Steiner B, York C, Mastrorilli J, Lake GA, Leibowitz S, Simmons L, Steppel-Reznik J, Low G, Fischer MA, Patorno E, Wexler DJ. PMID: 37985010; PMCID: PMC10841974.
      View in: PubMed   Mentions:
    38. High-Dose vs. Standard-Dose Influenza Vaccine and Cardiopulmonary Hospitalization or Mortality: Emulating the INVESTED Trial Using Insurance Claims Data. Clin Pharmacol Ther. 2024 01; 115(1):126-134. NajafZadeh M, Shin H, Schneeweiss S, Wang SV, Solomon SD, Vardeny O, Patorno E. PMID: 37853843; PMCID: PMC12787785.
      View in: PubMed   Mentions:
    39. Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes. Diabetes Care. 2023 11 01; 46(11):2004-2014. Kutz A, Kim DH, Wexler DJ, Liu J, Schneeweiss S, Glynn RJ, Patorno E. PMID: 37677118; PMCID: PMC10620535.
      View in: PubMed   Mentions:
    40. Real-World Continuous EEG Utilization and Outcomes in Hospitalized Patients With Acute Cerebrovascular Diseases. J Clin Neurophysiol. 2025 Jan 01; 42(1):20-27. Amerineni R, Sun H, Fernandes MB, Westover MB, Moura L, Patorno E, Hsu J, Zafar SF. PMID: 37938032; PMCID: PMC11058112.
      View in: PubMed   Mentions:
    41. Stratified analysis in comparative effectiveness studies that emulate randomized trials. Pharmacoepidemiol Drug Saf. 2024 01; 33(1):e5716. Htoo PT, Glynn RJ, Wang S, Paik JM, Schneeweiss S, Walker AM, Patorno E. PMID: 37876341.
      View in: PubMed   Mentions:
    42. Prognostic Factors of COVID-19: An Umbrella Review Endorsed by the International Society for Pharmacoepidemiology. Clin Pharmacol Ther. 2023 09; 114(3):604-613. Sarri G, Liu W, Zabotka L, Freitag A, Claire R, Wangge G, Elvidge J, Dawoud D, Bennett D, Wen X, Li X, Rentsch CT, Uddin MJ, Ali MS, Gokhale M, Déruaz-Luyet A, Moga DC, Guo JJ, Zullo AR, Patorno E, Lin KJ. PMID: 37342987; PMCID: PMC12024729.
      View in: PubMed   Mentions:
    43. Achieving comparability in glycemic control between antidiabetic treatment strategies in pregnancy when using real world data. Pharmacoepidemiol Drug Saf. 2023 12; 32(12):1350-1359. Cesta CE, Hernández-Díaz S, Huybrechts KF, Bateman BT, Vine S, Seely EW, Patorno E. PMID: 37461243; PMCID: PMC10792121.
      View in: PubMed   Mentions:
    44. Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom. Diabetes Obes Metab. 2023 10; 25(10):2980-2988. Abrahami D, D'Andrea E, Yin H, Kim SC, Paik JM, Wexler D, Azoulay L, Patorno E. PMID: 37395339; PMCID: PMC10527897.
      View in: PubMed   Mentions:
    45. Use of Real-World Data in Population Science to Improve the Prevention and Care of Diabetes-Related Outcomes. Diabetes Care. 2023 07 01; 46(7):1316-1326. Gregg EW, Patorno E, Karter AJ, Mehta R, Huang ES, White M, Patel CJ, McElvaine AT, Cefalu WT, Selby J, Riddle MC, Khunti K. PMID: 37339346; PMCID: PMC10300521.
      View in: PubMed   Mentions:
    46. Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study. Eur Heart J. 2023 06 25; 44(24):2216-2230. Fu EL, Patorno E, Everett BM, Vaduganathan M, Solomon SD, Levin R, Schneeweiss S, Desai RJ. PMID: 37259575; PMCID: PMC10290872.
      View in: PubMed   Mentions:
    47. Common non-cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular disease. J Am Geriatr Soc. 2023 10; 71(10):3179-3188. Sison SDM, Lin KJ, Najafzadeh M, Ko D, Patorno E, Bessette LG, Zakoul H, Kim DH. PMID: 37354026; PMCID: PMC10592495.
      View in: PubMed   Mentions:
    48. Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction. J Am Geriatr Soc. 2023 10; 71(10):3110-3121. Lee YC, Lin JK, Ko D, Cheng S, Patorno E, Glynn RJ, Tsacogianis T, Kim DH. PMID: 37345734; PMCID: PMC10592538.
      View in: PubMed   Mentions:
    49. Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD. Curr Opin Nephrol Hypertens. 2023 07 01; 32(4):324-329. Kaze AD, Patorno E, Paik JM. PMID: 37195239.
      View in: PubMed   Mentions:
    50. Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials. JAMA. 2023 Apr 25; 329(16):1376-1385. Wang SV, Schneeweiss S, RCT-DUPLICATE Initiative, Franklin JM, Desai RJ, Feldman W, Garry EM, Glynn RJ, Lin KJ, Paik J, Patorno E, Suissa S, D'Andrea E, Jawaid D, Lee H, Pawar A, Sreedhara SK, Tesfaye H, Bessette LG, Zabotka L, Lee SB, Gautam N, York C, Zakoul H, Concato J, Martin D, Paraoan D, Quinto K. PMID: 37097356; PMCID: PMC10130954.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    51. Continuous Glucose Monitoring in Adults with Diabetes in Clinical Practice: Increased Access and Education Needed. J Gen Intern Med. 2023 06; 38(8):2011-2014. Abrahami D, Hernández-Díaz S, Munshi MN, Patorno E. PMID: 37037982; PMCID: PMC10271995.
      View in: PubMed   Mentions:
    52. Antidiabetes medication initiation trends in US adults with cirrhosis and type 2 diabetes: A nationwide study. Diabetes Obes Metab. 2023 07; 25(7):2028-2033. Simon TG, Wexler DJ, Schneeweiss S, Patorno E. PMID: 36938914; PMCID: PMC10239316.
      View in: PubMed   Mentions:
    53. Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels. JAMA Intern Med. 2023 03 01; 183(3):242-254. D'Andrea E, Wexler DJ, Kim SC, Paik JM, Alt E, Patorno E. PMID: 36745425; PMCID: PMC9989905.
      View in: PubMed   Mentions:
    54. Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study. Clin J Am Soc Nephrol. 2023 05 01; 18(5):592-601. Fu EL, D'Andrea E, Wexler DJ, Patorno E, Paik JM. PMID: 36827225; PMCID: PMC10278835.
      View in: PubMed   Mentions:
    55. Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study. Diabetes Metab. 2023 03; 49(2):101418. Karasik A, Lanzinger S, Chia-Hui Tan E, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Ha KH, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K, Nyström T, Niskanen L, Linnemann Jensen M, Hoti F, Klement R, Déruaz-Luyet A, Kyaw MH, Koeneman L, Vistisen D, Carstensen B, Halvorsen S, Langslet G, Fazeli Farsani S, Patorno E, Núñez J, EMPRISE Europe and Asia Study Group. PMID: 36608816.
      View in: PubMed   Mentions:
    56. Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure. Diabetes Care. 2023 01 01; 46(1):65-74. Cromer SJ, Lauffenburger JC, Levin R, Patorno E. PMID: 36383481; PMCID: PMC9797651.
      View in: PubMed   Mentions:
    57. Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study. Diabetes Care. 2022 12 01; 45(12):2907-2917. Abrahami D, Tesfaye H, Yin H, Vine S, Hicks B, Yu OHY, Campeau L, Platt RW, Schneeweiss S, Patorno E, Azoulay L. PMID: 36170656; PMCID: PMC9998845.
      View in: PubMed   Mentions:
    58. Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin. Ann Intern Med. 2022 12; 175(12):W155. Shin H, Schneeweiss S, Glynn RJ, Patorno E. PMID: 36534995.
      View in: PubMed   Mentions:
    59. Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics. JAMA Netw Open. 2022 10 03; 5(10):e2237606. Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, Everett BM, Glynn RJ, Kim SC, Najafzadeh M, Koeneman L, Farsani SF, Déruaz-Luyet A, Paik JM, Patorno E. PMID: 36264574; PMCID: PMC9585433.
      View in: PubMed   Mentions:
    60. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes. JAMA Netw Open. 2022 10 03; 5(10):e2235995. Zhuo M, D'Andrea E, Paik JM, Wexler DJ, Everett BM, Glynn RJ, Kim SC, Patorno E. PMID: 36219443; PMCID: PMC9554705.
      View in: PubMed   Mentions:
    61. Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes. Diabetes Res Clin Pract. 2022 Oct; 192:110094. Suissa K, Schneeweiss S, Douros A, Yin H, Patorno E, Azoulay L. PMID: 36167266.
      View in: PubMed   Mentions:
    62. Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care. Am Heart J. 2022 Dec; 254:203-215. Desai RJ, Glynn RJ, Everett BM, Schneeweiss S, Wexler DJ, Bessette LG, Déruaz-Luyet A, Vedin O, Brodovicz K, Patorno E. PMID: 36150454.
      View in: PubMed   Mentions:
    63. Glucagon-Like Peptide 1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: A Multisite Population-Based Cohort Study. Am J Epidemiol. 2022 07 23; 191(8):1352-1367. Pradhan R, Patorno E, Tesfaye H, Schneeweiss S, Yin H, Franklin J, Pawar A, Santella C, Yu OHY, Renoux C, Azoulay L. PMID: 35136902; PMCID: PMC9989345.
      View in: PubMed   Mentions:
    64. Pradhan et al. Respond to "Large-Scale, Multisite Studies Using Real-World Data". Am J Epidemiol. 2022 07 23; 191(8):1372-1373. Pradhan R, Patorno E, Azoulay L. PMID: 35597823.
      View in: PubMed   Mentions:
    65. Machine learning for improving high-dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature. Pharmacoepidemiol Drug Saf. 2022 09; 31(9):932-943. Wyss R, Yanover C, El-Hay T, Bennett D, Platt RW, Zullo AR, Sari G, Wen X, Ye Y, Yuan H, Gokhale M, Patorno E, Lin KJ. PMID: 35729705; PMCID: PMC9541861.
      View in: PubMed   Mentions:
    66. Cardiovascular and Mortality Risk with Intravitreal Vascular Endothelial Growth Factor Inhibitors in Patients with Diabetic Retinopathy. Ophthalmol Retina. 2022 12; 6(12):1145-1153. Roh M, Tesfaye H, Kim SC, Zabotka LE, Patorno E. PMID: 35777664.
      View in: PubMed   Mentions:
    67. Anti-seizure medication treatment and outcomes in acute ischemic stroke patients undergoing continuous EEG monitoring. Neurol Sci. 2022 Sep; 43(9):5441-5449. Sanches PR, Tabaeizadeh M, Moura LMVR, Rosenthal ES, Caboclo LO, Hsu J, Patorno E, Westover MB, Zafar SF. PMID: 35713732; PMCID: PMC11550088.
      View in: PubMed   Mentions:
    68. Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study. Ann Intern Med. 2022 07; 175(7):927-937. Shin H, Schneeweiss S, Glynn RJ, Patorno E. PMID: 35605236.
      View in: PubMed   Mentions:
    69. Risk of Hospitalization for Heart Failure in Patients With Hyperkalemia Treated With Sodium Zirconium Cyclosilicate Versus Patiromer. J Card Fail. 2022 09; 28(9):1414-1423. Zhuo M, Kim SC, Patorno E, Paik JM. PMID: 35470055.
      View in: PubMed   Mentions:
    70. Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis. Cardiovasc Diabetol. 2022 03 23; 21(1):47. Kaze AD, Zhuo M, Kim SC, Patorno E, Paik JM. PMID: 35321742; PMCID: PMC9491404.
      View in: PubMed   Mentions:
    71. Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries. Diabetes Care. 2022 03 01; 45(3):604-613. Hawley CE, Lauffenburger JC, Paik JM, Wexler DJ, Kim SC, Patorno E. PMID: 35043165; PMCID: PMC8918201.
      View in: PubMed   Mentions:
    72. Evolving channeling in prescribing SGLT-2 inhibitors as first-line treatment for type 2 diabetes. Pharmacoepidemiol Drug Saf. 2022 05; 31(5):566-576. Shin H, Schneeweiss S, Glynn RJ, Patorno E. PMID: 34985178; PMCID: PMC8989653.
      View in: PubMed   Mentions:
    73. Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease. Ann Intern Med. 2022 01; 175(1):W4. Patorno E, Htoo PT, Everett BM, Kim SC. PMID: 35038405.
      View in: PubMed   Mentions:
    74. Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease. Ann Intern Med. 2022 01; 175(1):W4-W5. Patorno E, Htoo PT, Glynn RJ, Schneeweiss S, Wexler DJ, Pawar A, Bessette LG, Chin K, Everett BM, Kim SC. PMID: 35038404.
      View in: PubMed   Mentions:
    75. The use of glucose-lowering medications for the treatment of type 2 diabetes mellitus during pregnancy in the United States. Endocrinol Diabetes Metab. 2022 03; 5(2):e00319. Wood ME, Patorno E, Huybrechts KF, Bateman BT, Gray KJ, Seely EW, Vine S, Hernández-Díaz S. PMID: 34953068; PMCID: PMC8917861.
      View in: PubMed   Mentions:
    76. Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data. Pharmacoepidemiol Drug Saf. 2022 04; 31(4):467-475. Paik JM, Patorno E, Zhuo M, Bessette LG, York C, Gautam N, Kim DH, Kim SC. PMID: 34908211; PMCID: PMC8917076.
      View in: PubMed   Mentions:
    77. Web Exclusive. Annals On Call - SGLT2 Versus GLP1 for Cardiovascular Prevention. Ann Intern Med. 2021 12; 174(12):OC1. Centor RM, Patorno E. PMID: 34929127.
      View in: PubMed   Mentions:
    78. Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study. Diabetes Obes Metab. 2022 03; 24(3):442-454. Patorno E, Pawar A, Wexler DJ, Glynn RJ, Bessette LG, Paik JM, Najafzadeh M, Brodovicz KG, Déruaz-Luyet A, Schneeweiss S. PMID: 34729891; PMCID: PMC8939295.
      View in: PubMed   Mentions:
    79. Antiseizure Medication Treatment and Outcomes in Patients with Subarachnoid Hemorrhage Undergoing Continuous EEG Monitoring. Neurocrit Care. 2022 06; 36(3):857-867. Zafar SF, Rosenthal ES, Postma EN, Sanches P, Ayub MA, Rajan S, Kim JA, Rubin DB, Lee H, Patel AB, Hsu J, Patorno E, Westover MB. PMID: 34843082; PMCID: PMC9117405.
      View in: PubMed   Mentions:
    80. Using electronic health data to explore effectiveness of ICU EEG and anti-seizure treatment. Ann Clin Transl Neurol. 2021 12; 8(12):2270-2279. Amerineni R, Sun H, Lee H, Hsu J, Patorno E, Westover MB, Zafar SF. PMID: 34802196; PMCID: PMC8670316.
      View in: PubMed   Mentions:
    81. Misclassification of Obesity in Claims Data. Clin Transl Gastroenterol. 2021 11 18; 12(11):e00423. Suissa K, Kim SC, Patorno E. PMID: 34797225; PMCID: PMC8604028.
      View in: PubMed   Mentions:
    82. SGLT2 Inhibitors and the Risk of Acute Kidney Injury in Older Adults With Type 2 Diabetes. Am J Kidney Dis. 2022 06; 79(6):858-867.e1. Zhuo M, Paik JM, Wexler DJ, Bonventre JV, Kim SC, Patorno E. PMID: 34762974; PMCID: PMC9079190.
      View in: PubMed   Mentions:
    83. Linking the Paul Coverdell National Acute Stroke Program to commercial claims to establish a framework for real-world longitudinal stroke research. Stroke Vasc Neurol. 2022 04; 7(2):114-123. Patorno E, Schneeweiss S, George MG, Tong X, Franklin JM, Pawar A, Mogun H, Moura LMVR, Schwamm LH. PMID: 34750282; PMCID: PMC9067267.
      View in: PubMed   Mentions:
    84. Validation of a Claims-based Algorithm to Identify Pregestational Diabetes Among Pregnant Women in the United States. Epidemiology. 2021 11 01; 32(6):855-859. Wood ME, Chen ST, Huybrechts KF, Bateman BT, Gray KJ, Seely EW, Zhu Y, Mogun H, Patorno E, Hernández-Díaz S. PMID: 34183529; PMCID: PMC8478806.
      View in: PubMed   Mentions:
    85. Time to end the misuse of race in medicine: cases from nephrology. BMJ. 2021 10 19; 375:n2435. Gopalakrishnan C, Patorno E. PMID: 34667058.
      View in: PubMed   Mentions:
    86. Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes. JAMA Netw Open. 2021 10 01; 4(10):e2130762. Zhuo M, Hawley CE, Paik JM, Bessette LG, Wexler DJ, Kim DH, Tong AY, Kim SC, Patorno E. PMID: 34705014; PMCID: PMC8552056.
      View in: PubMed   Mentions:
    87. Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease. Ann Intern Med. 2021 11; 174(11):1528-1541. Patorno E, Htoo PT, Glynn RJ, Schneeweiss S, Wexler DJ, Pawar A, Bessette LG, Chin K, Everett BM, Kim SC. PMID: 34570599; PMCID: PMC8969214.
      View in: PubMed   Mentions:
    88. Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments. Endocr Rev. 2021 09 28; 42(5):658-690. Schneeweiss S, Patorno E. PMID: 33710268; PMCID: PMC8476933.
      View in: PubMed   Mentions:
    89. Validation of obesity-related diagnosis codes in claims data. Diabetes Obes Metab. 2021 12; 23(12):2623-2631. Suissa K, Schneeweiss S, Lin KJ, Brill G, Kim SC, Patorno E. PMID: 34338404; PMCID: PMC8578343.
      View in: PubMed   Mentions:
    90. Prevalence of Avoidable and Bias-Inflicting Methodological Pitfalls in Real-World Studies of Medication Safety and Effectiveness. Clin Pharmacol Ther. 2022 01; 111(1):209-217. Bykov K, Patorno E, D'Andrea E, He M, Lee H, Graff JS, Franklin JM. PMID: 34260087; PMCID: PMC8678198.
      View in: PubMed   Mentions:
    91. The modifying effects of adiposity on the cardiovascular safety of sulphonylureas. Diabetes Obes Metab. 2021 11; 23(11):2502-2512. Suissa K, Schneeweiss S, Douros A, Filion KB, Yin H, Patorno E, Azoulay L. PMID: 34251086.
      View in: PubMed   Mentions:
    92. Prescribing Trends of Antidiabetes Medications in Patients With Type 2 Diabetes and Diabetic Kidney Disease, a Cohort Study. Diabetes Care. 2021 Aug 03. Harris ST, Patorno E, Zhuo M, Kim SC, Paik JM. PMID: 34344714; PMCID: PMC8929186.
      View in: PubMed   Mentions:
    93. Comparative effectiveness and safety of sodium-glucose cotransporter-2 inhibitors versus metformin in patients with type 2 diabetes: An observational study using data from routine care. Diabetes Obes Metab. 2021 10; 23(10):2320-2328. Fralick M, Schneeweiss S, Redelmeier DA, Razak F, Gomes T, Patorno E. PMID: 34169619.
      View in: PubMed   Mentions:
    94. Glucagon-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes. Clin Gastroenterol Hepatol. 2022 06; 20(6):1382-1393.e19. Simon TG, Patorno E, Schneeweiss S. PMID: 34256144; PMCID: PMC8743301.
      View in: PubMed   Mentions:
    95. A General Propensity Score for Signal Identification Using Tree-Based Scan Statistics. Am J Epidemiol. 2021 07 01; 190(7):1424-1433. Wang SV, Maro JC, Gagne JJ, Patorno E, Kattinakere S, Stojanovic D, Eworuke E, Baro E, Ouellet-Hellstrom R, Nguyen M, Ma Y, Dashevsky I, Cole D, DeLuccia S, Hansbury A, Pestine E, Kulldorff M. PMID: 33615330.
      View in: PubMed   Mentions:
    96. Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA. Diabetes Care. 2021 08; 44(8):1774-1782. Shin H, Schneeweiss S, Glynn RJ, Patorno E. PMID: 34385345; PMCID: PMC8385465.
      View in: PubMed   Mentions:
    97. Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care. Heart. 2021 09; 107(17):1407-1416. Desai RJ, Patorno E, Vaduganathan M, Mahesri M, Chin K, Levin R, Solomon SD, Schneeweiss S. PMID: 34088766.
      View in: PubMed   Mentions:
    98. A novel data mining application to detect safety signals for newly approved medications in routine care of patients with diabetes. Endocrinol Diabetes Metab. 2021 Jul; 4(3):e00237. Fralick M, Kulldorff M, Redelmeier D, Wang SV, Vine S, Schneeweiss S, Patorno E. PMID: 34277962; PMCID: PMC8279599.
      View in: PubMed   Mentions:
    99. Prescribing trends and clinical characteristics of patients starting antiobesity drugs in the United States. Diabetes Obes Metab. 2021 07; 23(7):1542-1551. Suissa K, Schneeweiss S, Kim DW, Patorno E. PMID: 33651454.
      View in: PubMed   Mentions:
    100. How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools. BMJ Open. 2021 03 24; 11(3):e043961. D'Andrea E, Vinals L, Patorno E, Franklin JM, Bennett D, Largent JA, Moga DC, Yuan H, Wen X, Zullo AR, Debray TPA, Sarri G. PMID: 33762237; PMCID: PMC7993210.
      View in: PubMed   Mentions:
    101. Identifying Risk Factors for Diabetic Ketoacidosis Associated with SGLT2 Inhibitors: a Nationwide Cohort Study in the USA. J Gen Intern Med. 2021 09; 36(9):2601-2607. Fralick M, Redelmeier DA, Patorno E, Franklin JM, Razak F, Gomes T, Schneeweiss S. PMID: 33564942; PMCID: PMC8390572.
      View in: PubMed   Mentions:
    102. Comparative Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults. Diabetes Care. 2021 03; 44(3):826-835. Patorno E, Pawar A, Bessette LG, Kim DH, Dave C, Glynn RJ, Munshi MN, Schneeweiss S, Wexler DJ, Kim SC. PMID: 33495295; PMCID: PMC7896266.
      View in: PubMed   Mentions:
    103. Postoperative inpatient utilization of opioid and opioid-sparing analgesics in the United States hospitals, 2007-2017. Pharmacoepidemiol Drug Saf. 2021 03; 30(3):390-394. Bykov K, Patorno E, Franklin JM, Vine SM, Bateman BT. PMID: 33368798; PMCID: PMC7854478.
      View in: PubMed   Mentions:
    104. Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative. Circulation. 2021 03 09; 143(10):1002-1013. Franklin JM, Patorno E, Desai RJ, Glynn RJ, Martin D, Quinto K, Pawar A, Bessette LG, Lee H, Garry EM, Gautam N, Schneeweiss S. PMID: 33327727; PMCID: PMC7940583.
      View in: PubMed   Mentions:
    105. Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy. Circulation. 2021 02 23; 143(8):770-779. Dave CV, Kim SC, Goldfine AB, Glynn RJ, Tong A, Patorno E. PMID: 33302723; PMCID: PMC7902404.
      View in: PubMed   Mentions:
    106. Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making. BMJ Evid Based Med. 2022 04; 27(2):109-119. Sarri G, Patorno E, Yuan H, Guo JJ, Bennett D, Wen X, Zullo AR, Largent J, Panaccio M, Gokhale M, Moga DC, Ali MS, Debray TPA. PMID: 33298465; PMCID: PMC8961747.
      View in: PubMed   Mentions:
    107. Association of Gabapentinoids With the Risk of Opioid-Related Adverse Events in Surgical Patients in the United States. JAMA Netw Open. 2020 12 01; 3(12):e2031647. Bykov K, Bateman BT, Franklin JM, Vine SM, Patorno E. PMID: 33372975; PMCID: PMC7772715.
      View in: PubMed   Mentions:
    108. Epidemiologic Characterization of Heart Failure with Reduced or Preserved Ejection Fraction Populations Identified Using Medicare Claims. Am J Med. 2021 04; 134(4):e241-e251. Desai RJ, Mahesri M, Chin K, Levin R, Lahoz R, Studer R, Vaduganathan M, Patorno E. PMID: 33127370.
      View in: PubMed   Mentions:
    109. Evaluation of Risk of Bullous Pemphigoid With Initiation of Dipeptidyl Peptidase-4 Inhibitor vs Second-generation Sulfonylurea. JAMA Dermatol. 2020 10 01; 156(10):1107-1114. Lee H, Chung HJ, Pawar A, Patorno E, Kim DH. PMID: 32697283.
      View in: PubMed   Mentions:
    110. Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis. Cardiovasc Diabetol. 2020 09 29; 19(1):154. D'Andrea E, Kesselheim AS, Franklin JM, Jung EH, Hey SP, Patorno E. PMID: 32993654; PMCID: PMC7525990.
      View in: PubMed   Mentions:
    111. Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: A population-based cohort study nested in the US Medicaid Analytic eXtract dataset. PLoS Med. 2020 09; 17(9):e1003322. Patorno E, Hernandez-Diaz S, Huybrechts KF, Desai RJ, Cohen JM, Mogun H, Bateman BT. PMID: 32870921; PMCID: PMC7462308.
      View in: PubMed   Mentions:
    112. Bias Implications of Outcome Misclassification in Observational Studies Evaluating Association Between Treatments and All-Cause or Cardiovascular Mortality Using Administrative Claims. J Am Heart Assoc. 2020 09; 9(17):e016906. Desai RJ, Levin R, Lin KJ, Patorno E. PMID: 32844711; PMCID: PMC7660765.
      View in: PubMed   Mentions:
    113. Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study. BMJ. 2020 08 25; 370:m2812. Fralick M, Kim SC, Schneeweiss S, Everett BM, Glynn RJ, Patorno E. PMID: 32843476; PMCID: PMC7445737.
      View in: PubMed   Mentions:
    114. Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model. Clin Epidemiol. 2020; 12:607-616. Lee MP, Glynn RJ, Schneeweiss S, Lin KJ, Patorno E, Barberio J, Levin R, Evers T, Wang SV, Desai RJ. PMID: 32606986; PMCID: PMC7304674.
      View in: PubMed   Mentions:
    115. Measuring Frailty in Administrative Claims Data: Comparative Performance of Four Claims-Based Frailty Measures in the U.S. Medicare Data. J Gerontol A Biol Sci Med Sci. 2020 05 22; 75(6):1120-1125. Kim DH, Patorno E, Pawar A, Lee H, Schneeweiss S, Glynn RJ. PMID: 31566201; PMCID: PMC7243587.
      View in: PubMed   Mentions:
    116. Transparency in real-world evidence (RWE) studies to build confidence for decision-making: Reporting RWE research in diabetes. Diabetes Obes Metab. 2020 04; 22 Suppl 3:45-59. Patorno E, Schneeweiss S, Wang SV. PMID: 32250527; PMCID: PMC7472869.
      View in: PubMed   Mentions:
    117. Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes Medications. Value Health. 2020 04; 23(4):434-440. Fralick M, Gagne JJ, Patorno E, Levin R, Kesselheim AS. PMID: 32327160.
      View in: PubMed   Mentions:
    118. Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013-2018. Diabetes Care. 2020 04; 43(4):921-924. Dave CV, Schneeweiss S, Wexler DJ, Brill G, Patorno E. PMID: 32041899; PMCID: PMC7519473.
      View in: PubMed   Mentions:
    119. PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid. Diabetes. 2020 04; 69(4):771-783. Morieri ML, Shah HS, Sjaarda J, Lenzini PA, Campbell H, Motsinger-Reif AA, Gao H, Lovato L, Prudente S, Pandolfi A, Pezzolesi MG, Sigal RJ, Paré G, Marcovina SM, Rotroff DM, Patorno E, Mercuri L, Trischitta V, Chew EY, Kraft P, Buse JB, Wagner MJ, Cresci S, Gerstein HC, Ginsberg HN, Mychaleckyj JC, Doria A. PMID: 31974142; PMCID: PMC7085251.
      View in: PubMed   Mentions:
    120. Assessing the Risk for Gout With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Population-Based Cohort Study. Ann Intern Med. 2020 02 04; 172(3):186-194. Fralick M, Chen SK, Patorno E, Kim SC. PMID: 31931526; PMCID: PMC7217750.
      View in: PubMed   Mentions:
    121. Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections. Ann Intern Med. 2019 12 17; 171(12):944-945. Dave CV, Schneeweiss S, Kim D, Fralick M, Patorno E. PMID: 31842209.
      View in: PubMed   Mentions:
    122. Exendin-based glucagon-like peptide-1 receptor agonists and anaphylactic reactions: a pharmacovigilance analysis. Lancet Diabetes Endocrinol. 2020 01; 8(1):13-14. Pradhan R, Montastruc F, Rousseau V, Patorno E, Azoulay L. PMID: 31806579.
      View in: PubMed   Mentions:
    123. Measuring the Effectiveness of Safety Warnings on the Risk of Stroke in Older Antipsychotic Users: A Nationwide Cohort Study in Two Large Electronic Medical Records Databases in the United Kingdom and Italy. Drug Saf. 2019 12; 42(12):1471-1485. Sultana J, Fontana A, Giorgianni F, Tillati S, Cricelli C, Pasqua A, Patorno E, Ballard C, Sturkenboom M, Trifirò G. PMID: 31556019.
      View in: PubMed   Mentions:
    124. The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care. Endocrinol Diabetes Metab. 2020 Jan; 3(1):e00103. Patorno E, Najafzadeh M, Pawar A, Franklin JM, Déruaz-Luyet A, Brodovicz KG, Santiago Ortiz AJ, Bessette LG, Kulldorff M, Schneeweiss S. PMID: 31922030; PMCID: PMC6947693.
      View in: PubMed   Mentions:
    125. Impact of State Laws Restricting Opioid Duration on Characteristics of New Opioid Prescriptions. J Gen Intern Med. 2019 11; 34(11):2339-2341. Dave CV, Patorno E, Franklin JM, Huybrechts K, Sarpatwari A, Kesselheim AS, Bateman BT. PMID: 31309407; PMCID: PMC6848320.
      View in: PubMed   Mentions:
    126. Association of Sodium-Glucose Cotransporter 2 Inhibitor Treatment With Risk of Hospitalization for Fournier Gangrene Among Men. JAMA Intern Med. 2019 Nov 01; 179(11):1587-1590. Dave CV, Schneeweiss S, Patorno E. PMID: 31479145; PMCID: PMC6724526.
      View in: PubMed   Mentions:
    127. Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study. Ann Intern Med. 2019 08 20; 171(4):248-256. Dave CV, Schneeweiss S, Kim D, Fralick M, Tong A, Patorno E. PMID: 31357213; PMCID: PMC6989379.
      View in: PubMed   Mentions:
    128. Fracture Risk After Initiation of Use of Canagliflozin. Ann Intern Med. 2019 07 02; 171(1):80. Fralick M, Kim SC, Schneeweiss S, Kim D, Redelmeier DA, Patorno E. PMID: 31261403.
      View in: PubMed   Mentions:
    129. Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride. Diabetes Care. 2019 12; 42(12):2204-2210. Patorno E, Schneeweiss S, Gopalakrishnan C, Martin D, Franklin JM. PMID: 31239281; PMCID: PMC6868466.
      View in: PubMed   Mentions:
    130. Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes. J Clin Psychiatry. 2019 06 18; 80(4). Cohen JM, Huybrechts KF, Patorno E, Desai RJ, Mogun H, Bateman BT, Hernández-Díaz S. PMID: 31237992.
      View in: PubMed   Mentions:
    131. Glucose-lowering medications and the risk of cancer: A methodological review of studies based on real-world data. Diabetes Obes Metab. 2019 09; 21(9):2029-2038. Bykov K, He M, Franklin JM, Garry EM, Seeger JD, Patorno E. PMID: 31062453; PMCID: PMC6684441.
      View in: PubMed   Mentions:
    132. A tool for empirical equipoise assessment in multigroup comparative effectiveness research. Pharmacoepidemiol Drug Saf. 2019 07; 28(7):934-941. Yoshida K, Solomon DH, Haneuse S, Kim SC, Patorno E, Tedeschi SK, Lyu H, Hernández-Díaz S, Glynn RJ. PMID: 31131965; PMCID: PMC7057252.
      View in: PubMed   Mentions:
    133. Cardiovascular safety of linagliptin compared with other oral glucose-lowering agents in patients with type 2 diabetes: A sequential monitoring programme in routine care. Diabetes Obes Metab. 2019 08; 21(8):1824-1836. Patorno E, Gopalakrishnan C, Brodovicz KG, Meyers A, Bartels DB, Liu J, Kulldorff M, Schneeweiss S. PMID: 30941884; PMCID: PMC6785989.
      View in: PubMed   Mentions:
    134. Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care. Circulation. 2019 06 18; 139(25):2822-2830. Patorno E, Pawar A, Franklin JM, Najafzadeh M, Déruaz-Luyet A, Brodovicz KG, Sambevski S, Bessette LG, Santiago Ortiz AJ, Kulldorff M, Schneeweiss S. PMID: 30955357; PMCID: PMC6594384.
      View in: PubMed   Mentions:
    135. Multinomial Extension of Propensity Score Trimming Methods: A Simulation Study. Am J Epidemiol. 2019 03 01; 188(3):609-616. Yoshida K, Solomon DH, Haneuse S, Kim SC, Patorno E, Tedeschi SK, Lyu H, Franklin JM, Stürmer T, Hernández-Díaz S, Glynn RJ. PMID: 30517602; PMCID: PMC6395163.
      View in: PubMed   Mentions:
    136. Antipsychotic utilization patterns among patients with schizophrenic disorder: a cross-national analysis in four countries. Eur J Clin Pharmacol. 2019 Jul; 75(7):1005-1015. Sultana J, Hurtado I, Bejarano-Quisoboni D, Giorgianni F, Huybrechts KF, Lu Z, Patorno E, Sanfélix-Gimeno G, Tari DU, Trifirò G. PMID: 30824947.
      View in: PubMed   Mentions:
    137. Days' Supply of Initial Opioid Analgesic Prescriptions and Additional Fills for Acute Pain Conditions Treated in the Primary Care Setting - United States, 2014. MMWR Morb Mortal Wkly Rep. 2019 Feb 15; 68(6):140-143. Mundkur ML, Franklin JM, Abdia Y, Huybrechts KF, Patorno E, Gagne JJ, Meyer TE, Staffa J, Bateman BT. PMID: 30763301; PMCID: PMC6375655.
      View in: PubMed   Mentions:
    138. Fracture Risk After Initiation of Use of Canagliflozin: A Cohort Study. Ann Intern Med. 2019 02 05; 170(3):155-163. Fralick M, Kim SC, Schneeweiss S, Kim D, Redelmeier DA, Patorno E. PMID: 30597484; PMCID: PMC6602870.
      View in: PubMed   Mentions:
    139. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring. JAMA. 2018 12 18; 320(23):2429-2437. Huybrechts KF, Hernández-Díaz S, Straub L, Gray KJ, Zhu Y, Patorno E, Desai RJ, Mogun H, Bateman BT. PMID: 30561479; PMCID: PMC6669077.
      View in: PubMed   Mentions:
    140. Changes in Outpatient Use of Antibiotics by Adults in the United States, 2006-2015. Drug Saf. 2018 12; 41(12):1333-1342. Mundkur ML, Franklin J, Huybrechts KF, Fischer MA, Kesselheim AS, Linder JA, Landon J, Patorno E. PMID: 29987757.
      View in: PubMed   Mentions:
    141. Development and Preliminary Validation of a Medicare Claims-Based Model to Predict Left Ventricular Ejection Fraction Class in Patients With Heart Failure. Circ Cardiovasc Qual Outcomes. 2018 12; 11(12):e004700. Desai RJ, Lin KJ, Patorno E, Barberio J, Lee M, Levin R, Evers T, Wang SV, Schneeweiss S. PMID: 30562067.
      View in: PubMed   Mentions:
    142. Data Mining for Adverse Drug Events With a Propensity Score-matched Tree-based Scan Statistic. Epidemiology. 2018 11; 29(6):895-903. Wang SV, Maro JC, Baro E, Izem R, Dashevsky I, Rogers JR, Nguyen M, Gagne JJ, Patorno E, Huybrechts KF, Major JM, Zhou E, Reidy M, Cosgrove A, Schneeweiss S, Kulldorff M. PMID: 30074538; PMCID: PMC6167151.
      View in: PubMed   Mentions:
    143. Comparative effectiveness and safety of antiplatelet drugs in patients with diabetes mellitus and acute coronary syndrome. Pharmacoepidemiol Drug Saf. 2018 Dec; 27(12):1361-1370. Spoendlin J, Gagne JJ, Lewey JJ, Patorno E, Schneeweiss S, Desai RJ. PMID: 30379372.
      View in: PubMed   Mentions:
    144. Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitors. Diabetes Obes Metab. 2019 02; 21(2):434-438. Dave CV, Schneeweiss S, Patorno E. PMID: 30207042; PMCID: PMC6329650.
      View in: PubMed   Mentions:
    145. Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Amputation: Results and Challenges From the Real World. JAMA Intern Med. 2018 09 01; 178(9):1199-1200. Fralick M, Patorno E, Fischer MA. PMID: 30105365.
      View in: PubMed   Mentions:
    146. Opioid Overdose After Surgical Discharge. JAMA. 2018 Aug 07; 320(5):502-504. Ladha KS, Gagne JJ, Patorno E, Huybrechts KF, Rathmell JP, Wang SV, Bateman BT. PMID: 30087999; PMCID: PMC6142985.
      View in: PubMed   Mentions:
    147. Anticonvulsants and the risk of perinatal bleeding complications: A pregnancy cohort study. Neurology. 2018 08 07; 91(6):e533-e542. Panchaud A, Cohen JM, Patorno E, Huybrechts KF, Desai RJ, Gray KJ, Mogun H, Hernandez-Diaz S, Bateman BT. PMID: 29980637; PMCID: PMC6105051.
      View in: PubMed   Mentions:
    148. Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney disease. Pharmacoepidemiol Drug Saf. 2018 08; 27(8):872-877. Smith DH, Shetterly S, Flory J, Haynes K, Lu CY, Gagne JJ, Herrinton L, Nyirenda C, Patorno E, Shoaibi A, Raebel MA. PMID: 29932281.
      View in: PubMed   Mentions:
    149. Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG). Clin Pharmacol Ther. 2018 08; 104(2):239-241. Yuan H, Ali MS, Brouwer ES, Girman CJ, Guo JJ, Lund JL, Patorno E, Slaughter JL, Wen X, Bennett D, ISPE Comparative Effectiveness Research Special Interest Group. PMID: 29733448.
      View in: PubMed   Mentions:
    150. Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. Am J Psychiatry. 2018 06 01; 175(6):564-574. Park Y, Hernandez-Diaz S, Bateman BT, Cohen JM, Desai RJ, Patorno E, Glynn RJ, Cohen LS, Mogun H, Huybrechts KF. PMID: 29730938; PMCID: PMC5988929.
      View in: PubMed   Mentions:
    151. Using prescription claims to detect aberrant behaviors with opioids: comparison and validation of 5 algorithms. Pharmacoepidemiol Drug Saf. 2019 01; 28(1):62-69. Rough K, Huybrechts KF, Hernandez-Diaz S, Desai RJ, Patorno E, Bateman BT. PMID: 29687539; PMCID: PMC6200661.
      View in: PubMed   Mentions:
    152. Use of haloperidol versus atypical antipsychotics and risk of in-hospital death in patients with acute myocardial infarction: cohort study. BMJ. 2018 03 28; 360:k1218. Park Y, Bateman BT, Kim DH, Hernandez-Diaz S, Patorno E, Glynn RJ, Mogun H, Huybrechts KF. PMID: 29592958; PMCID: PMC5871903.
      View in: PubMed   Mentions:
    153. Safety and Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists: Pilot Implementation of a Near-Real-Time Monitoring Program in Italy. J Am Heart Assoc. 2018 03 10; 7(6). Mayer F, Kirchmayer U, Coletta P, Agabiti N, Belleudi V, Cappai G, Di Martino M, Schneeweiss S, Davoli M, Patorno E. PMID: 29525786; PMCID: PMC5907561.
      View in: PubMed   Mentions:
    154. Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study. BMJ. 2018 02 06; 360:k119. Patorno E, Goldfine AB, Schneeweiss S, Everett BM, Glynn RJ, Liu J, Kim SC. PMID: 29437648; PMCID: PMC5799855.
      View in: PubMed   Mentions:
    155. Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study. J Am Heart Assoc. 2018 01 24; 7(3). Kang EH, Jin Y, Brill G, Lewey J, Patorno E, Desai RJ, Kim SC. PMID: 29367417; PMCID: PMC5850244.
      View in: PubMed   Mentions:
    156. Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records. Diabetes Obes Metab. 2018 04; 20(4):974-984. Patorno E, Gopalakrishnan C, Franklin JM, Brodovicz KG, Masso-Gonzalez E, Bartels DB, Liu J, Schneeweiss S. PMID: 29206336; PMCID: PMC6207375.
      View in: PubMed   Mentions:
    157. Topiramate use early in pregnancy and the risk of oral clefts: A pregnancy cohort study. Neurology. 2018 01 23; 90(4):e342-e351. Hernandez-Diaz S, Huybrechts KF, Desai RJ, Cohen JM, Mogun H, Pennell PB, Bateman BT, Patorno E. PMID: 29282333; PMCID: PMC5798655.
      View in: PubMed   Mentions:
    158. Can information on functional and cognitive status improve short-term mortality risk prediction among community-dwelling older people? A cohort study using a UK primary care database. Clin Epidemiol. 2018; 10:31-39. Sultana J, Fontana A, Giorgianni F, Basile G, Patorno E, Pilotto A, Molokhia M, Stewart R, Sturkenboom M, Trifirò G. PMID: 29296099; PMCID: PMC5741068.
      View in: PubMed   Mentions:
    159. Placental Complications Associated With Psychostimulant Use in Pregnancy. Obstet Gynecol. 2017 12; 130(6):1192-1201. Cohen JM, Hernández-Díaz S, Bateman BT, Park Y, Desai RJ, Gray KJ, Patorno E, Mogun H, Huybrechts KF. PMID: 29112657; PMCID: PMC5709205.
      View in: PubMed   Mentions:
    160. Preferential prescribing and utilization trends of diabetes medications among patients with renal impairment: Emerging role of linagliptin and other dipeptidyl peptidase 4 inhibitors. Endocrinol Diabetes Metab. 2018 Jan; 1(1):e00005. Patorno E, Gopalakrishnan C, Bartels DB, Brodovicz KG, Liu J, Schneeweiss S. PMID: 30815542; PMCID: PMC6360917.
      View in: PubMed   Mentions:
    161. Patterns of opioid initiation at first visits for pain in United States primary care settings. Pharmacoepidemiol Drug Saf. 2018 05; 27(5):495-503. Mundkur ML, Rough K, Huybrechts KF, Levin R, Gagne JJ, Desai RJ, Patorno E, Choudhry NK, Bateman BT. PMID: 28971545; PMCID: PMC5880749.
      View in: PubMed   Mentions:
    162. Lithium Use in Pregnancy and the Risk of Cardiac Malformations. N Engl J Med. 2017 08 31; 377(9):893-894. Patorno E, Huybrechts KF, Hernandez-Diaz S. PMID: 28854098.
      View in: PubMed   Mentions:
    163. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study. BMJ. 2017 Aug 02; 358:j3326. Huybrechts KF, Bateman BT, Desai RJ, Hernandez-Diaz S, Rough K, Mogun H, Kerzner LS, Davis JM, Stover M, Bartels D, Cottral J, Patorno E. PMID: 28768628; PMCID: PMC5538591.
      View in: PubMed   Mentions:
    164. Benzodiazepines and risk of all cause mortality in adults: cohort study. BMJ. 2017 Jul 06; 358:j2941. Patorno E, Glynn RJ, Levin R, Lee MP, Huybrechts KF. PMID: 28684397; PMCID: PMC5499256.
      View in: PubMed   Mentions:
    165. Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States. Psychiatr Serv. 2017 Nov 01; 68(11):1112-1119. Park Y, Huybrechts KF, Cohen JM, Bateman BT, Desai RJ, Patorno E, Mogun H, Cohen LS, Hernandez-Diaz S. PMID: 28617210; PMCID: PMC5665733.
      View in: PubMed   Mentions:
    166. Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor. N Engl J Med. 2017 06 08; 376(23):2300-2302. Fralick M, Schneeweiss S, Patorno E. PMID: 28591538.
      View in: PubMed   Mentions:
    167. Lithium Use in Pregnancy and the Risk of Cardiac Malformations. N Engl J Med. 2017 06 08; 376(23):2245-2254. Patorno E, Huybrechts KF, Bateman BT, Cohen JM, Desai RJ, Mogun H, Cohen LS, Hernandez-Diaz S. PMID: 28591541; PMCID: PMC5667676.
      View in: PubMed   Mentions:
    168. Evaluation of algorithms to identify delirium in administrative claims and drug utilization database. Pharmacoepidemiol Drug Saf. 2017 Aug; 26(8):945-953. Kim DH, Lee J, Kim CA, Huybrechts KF, Bateman BT, Patorno E, Marcantonio ER. PMID: 28485014; PMCID: PMC5583076.
      View in: PubMed   Mentions:
    169. Pregabalin use early in pregnancy and the risk of major congenital malformations. Neurology. 2017 May 23; 88(21):2020-2025. Patorno E, Bateman BT, Huybrechts KF, MacDonald SC, Cohen JM, Desai RJ, Panchaud A, Mogun H, Pennell PB, Hernandez-Diaz S. PMID: 28446648; PMCID: PMC5440246.
      View in: PubMed   Mentions:
    170. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ. 2017 Mar 06; 356:j895. Desai RJ, Bateman BT, Huybrechts KF, Patorno E, Hernandez-Diaz S, Park Y, Dejene SZ, Cohen J, Mogun H, Kim SC. PMID: 28264814; PMCID: PMC6168035.
      View in: PubMed   Mentions:
    171. Variable Selection for Confounding Adjustment in High-dimensional Covariate Spaces When Analyzing Healthcare Databases. Epidemiology. 2017 03; 28(2):237-248. Schneeweiss S, Eddings W, Glynn RJ, Patorno E, Rassen J, Franklin JM. PMID: 27779497.
      View in: PubMed   Mentions:
    172. Adverse Events Associated with Antipsychotic Use in Hospitalized Older Adults After Cardiac Surgery. J Am Geriatr Soc. 2017 Jun; 65(6):1229-1237. Kim DH, Huybrechts KF, Patorno E, Marcantonio ER, Park Y, Levin R, Abdurrob A, Bateman BT. PMID: 28186624; PMCID: PMC5478449.
      View in: PubMed   Mentions:
    173. Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations. Obstet Gynecol. 2017 01; 129(1):174-184. Bateman BT, Patorno E, Desai RJ, Seely EW, Mogun H, Dejene SZ, Fischer MA, Friedman AM, Hernandez-Diaz S, Huybrechts KF. PMID: 27926639; PMCID: PMC5177460.
      View in: PubMed   Mentions:
    174. The Role of Hemoglobin Laboratory Test Results for the Detection of Upper Gastrointestinal Bleeding Outcomes Resulting from the Use of Medications in Observational Studies. Drug Saf. 2017 01; 40(1):91-100. Patorno E, Gagne JJ, Lu CY, Haynes K, Sterrett AT, Roy J, Wang X, Raebel MA. PMID: 27848201.
      View in: PubMed   Mentions:
    175. Missing laboratory results data in electronic health databases: implications for monitoring diabetes risk. J Comp Eff Res. 2017 Jan; 6(1):25-32. Flory JH, Roy J, Gagne JJ, Haynes K, Herrinton L, Lu C, Patorno E, Shoaibi A, Raebel MA. PMID: 27935320.
      View in: PubMed   Mentions:
    176. Role of Tiotropium in Reducing Exacerbations of Chronic Obstructive Pulmonary Disease When Combined With Long-Acting β2 -Agonists and Inhaled Corticosteroids: The OUTPUL Study. J Clin Pharmacol. 2016 11; 56(11):1423-1432. Ferroni E, Belleudi V, Cascini S, Di Martino M, Kirchmayer U, Pistelli R, Patorno E, Formoso G, Fusco D, Perucci CA, Davoli M, Agabiti N, OUTPUL Study Group. PMID: 27095425; PMCID: PMC5111769.
      View in: PubMed   Mentions:
    177. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA Psychiatry. 2016 09 01; 73(9):938-46. Huybrechts KF, Hernández-Díaz S, Patorno E, Desai RJ, Mogun H, Dejene SZ, Cohen JM, Panchaud A, Cohen L, Bateman BT. PMID: 27540849; PMCID: PMC5321163.
      View in: PubMed   Mentions:
    178. Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia. Pediatrics. 2016 09; 138(3). Bateman BT, Patorno E, Desai RJ, Seely EW, Mogun H, Maeda A, Fischer MA, Hernandez-Diaz S, Huybrechts KF. PMID: 27577580; PMCID: PMC5005024.
      View in: PubMed   Mentions:
    179. Limited Hospital Variation in the Use and Yield of CT for Pulmonary Embolism in Patients Undergoing Total Hip or Total Knee Replacement Surgery. Radiology. 2016 Dec; 281(3):826-834. Kumamaru KK, Kumamaru H, Bateman BT, Gronsbell J, Cai T, Liu J, Higgins LD, Aoki S, Ohtomo K, Rybicki FJ, Patorno E. PMID: 27228331.
      View in: PubMed   Mentions:
    180. Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected. Pharmacoepidemiol Drug Saf. 2016 07; 25(7):798-814. Raebel MA, Shetterly S, Lu CY, Flory J, Gagne JJ, Harrell FE, Haynes K, Herrinton LJ, Patorno E, Popovic J, Selvan M, Shoaibi A, Wang X, Roy J. PMID: 27146273.
      View in: PubMed   Mentions:
    181. Comparative cardiovascular safety of glucagon-like peptide-1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study. Diabetes Obes Metab. 2016 08; 18(8):755-65. Patorno E, Everett BM, Goldfine AB, Glynn RJ, Liu J, Gopalakrishnan C, Kim SC. PMID: 27003762.
      View in: PubMed   Mentions:
    182. Brief Report: Patterns and Secular Trends in Use of Immunomodulatory Agents During Pregnancy in Women With Rheumatic Conditions. Arthritis Rheumatol. 2016 05; 68(5):1183-9. Desai RJ, Huybrechts KF, Bateman BT, Hernandez-Diaz S, Mogun H, Gopalakrishnan C, Patorno E, Kim SC. PMID: 26606742; PMCID: PMC4848128.
      View in: PubMed   Mentions:
    183. Variations in the Use of Perioperative Multimodal Analgesic Therapy. Anesthesiology. 2016 Apr; 124(4):837-45. Ladha KS, Patorno E, Huybrechts KF, Liu J, Rathmell JP, Bateman BT. PMID: 26835644; PMCID: PMC4792695.
      View in: PubMed   Mentions:
    184. Suppression of Substance Abuse Claims in Medicaid Data and Rates of Diagnoses for Non-Substance Abuse Conditions. JAMA. 2016 Mar 15; 315(11):1164-6. Rough K, Bateman BT, Patorno E, Desai RJ, Park Y, Hernandez-Diaz S, Huybrechts KF. PMID: 26978213; PMCID: PMC4794113.
      View in: PubMed   Mentions:
    185. Impact of Perioperative Epidural Placement on Postdischarge Opioid Use in Patients Undergoing Abdominal Surgery. Anesthesiology. 2016 Feb; 124(2):396-403. Ladha KS, Patorno E, Liu J, Bateman BT. PMID: 26575145; PMCID: PMC4718880.
      View in: PubMed   Mentions:
    186. One-year mortality associated with COPD treatment: a comparison of tiotropium and long-acting beta2-agonists in three Italian regions: results from the OUTPUL study. Pharmacoepidemiol Drug Saf. 2016 05; 25(5):578-89. Kirchmayer U, Cascini S, Agabiti N, Di Martino M, Bauleo L, Formoso G, Voci C, Pistelli R, Patorno E, Davoli M, OUTPUL study group. PMID: 26822968; PMCID: PMC5066679.
      View in: PubMed   Mentions:
    187. The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy. COPD. 2016 06; 13(3):293-302. Di Martino M, Agabiti N, Cascini S, Kirchmayer U, Bauleo L, Fusco D, Belleudi V, Pinnarelli L, Voci C, Patorno E, Pistelli R, Davoli M, OUTPUL Study Group. PMID: 26514912.
      View in: PubMed   Mentions:
    188. Patients' perception about risks and benefits of antithrombotic treatment for the prevention of venous thromboembolism (VTE) after orthopedic surgery: a qualitative study. BMC Musculoskelet Disord. 2015 Oct 26; 16:319. Najafzadeh M, Kim SC, Patterson C, Schneeweiss S, Katz JN, Brick GW, Ready JE, Polinski JM, Patorno E. PMID: 26503220; PMCID: PMC4624375.
      View in: PubMed   Mentions:
    189. Initiation patterns of statin therapy among adult patients undergoing intermediate to high-risk non-cardiac surgery. Pharmacoepidemiol Drug Saf. 2016 Jan; 25(1):64-72. Patorno E, Wang SV, Schneeweiss S, Liu J, Bateman BT. PMID: 26494361; PMCID: PMC4843110.
      View in: PubMed   Mentions:
    190. Calcium Channel Blocker Exposure in Late Pregnancy and the Risk of Neonatal Seizures. Obstet Gynecol. 2015 Aug; 126(2):271-278. Bateman BT, Huybrechts KF, Maeda A, Desai R, Patorno E, Seely EW, Ecker JL, Allen-Coleman C, Mogun H, Hernandez-Diaz S, Fischer MA. PMID: 26241414; PMCID: PMC4526118.
      View in: PubMed   Mentions:
    191. Patterns of β-blocker initiation in patients undergoing intermediate to high-risk noncardiac surgery. Am Heart J. 2015 Oct; 170(4):812-820.e6. Patorno E, Wang SV, Schneeweiss S, Liu J, Bateman BT. PMID: 26386806; PMCID: PMC7810354.
      View in: PubMed   Mentions:
    192. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA. 2015 Jun 02; 313(21):2142-51. Huybrechts KF, Bateman BT, Palmsten K, Desai RJ, Patorno E, Gopalakrishnan C, Levin R, Mogun H, Hernandez-Diaz S. PMID: 26034955; PMCID: PMC4761452.
      View in: PubMed   Mentions:
    193. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 2015 May 14; 350:h2102. Desai RJ, Huybrechts KF, Hernandez-Diaz S, Mogun H, Patorno E, Kaltenbach K, Kerzner LS, Bateman BT. PMID: 25975601; PMCID: PMC4431352.
      View in: PubMed   Mentions:
    194. Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review. Drug Saf. 2015 Mar; 38(3):295-310. Patorno E, Garry EM, Patrick AR, Schneeweiss S, Gillet VG, Zorina O, Bartels DB, Seeger JD. PMID: 25761856.
      View in: PubMed   Mentions:
    195. Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations. Diabetologia. 2014 Nov; 57(11):2237-50. Patorno E, Patrick AR, Garry EM, Schneeweiss S, Gillet VG, Bartels DB, Masso-Gonzalez E, Seeger JD. PMID: 25212258.
      View in: PubMed   Mentions:
    196. Authors' reply to Gupta. BMJ. 2014 Jul 30; 349:g4873. Patorno E, Bateman BT. PMID: 25078880.
      View in: PubMed   Mentions:
    197. Comparative safety of anesthetic type for hip fracture surgery in adults: retrospective cohort study. BMJ. 2014 Jun 27; 348:g4022. Patorno E, Neuman MD, Schneeweiss S, Mogun H, Bateman BT. PMID: 24972901; PMCID: PMC4073666.
      View in: PubMed   Mentions:
    198. Studies with many covariates and few outcomes: selecting covariates and implementing propensity-score-based confounding adjustments. Epidemiology. 2014 Mar; 25(2):268-78. Patorno E, Glynn RJ, Hernández-Díaz S, Liu J, Schneeweiss S. PMID: 24487209.
      View in: PubMed   Mentions:
    199. Use patterns of long-acting bronchodilators in routine COPD care: the OUTPUL study. COPD. 2014 Aug; 11(4):414-23. Di Martino M, Agabiti N, Bauleo L, Kirchmayer U, Cascini S, Pistelli R, Colamesta V, Patorno E, Pinnarelli L, Fusco D, Perucci CA, Davoli M, OUTPUL Study Group. PMID: 24090036.
      View in: PubMed   Mentions:
    200. Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settings. J Am Heart Assoc. 2013 Jul 30; 2(4):e000208. Patorno E, Glynn RJ, Hernandez-Diaz S, Avorn J, Wahl PM, Bohn RL, Mines D, Liu J, Schneeweiss S. PMID: 23900213; PMCID: PMC3828795.
      View in: PubMed   Mentions:
    201. Perioperative factors associated with prolonged mechanical ventilation after complex congenital heart surgery. Pediatr Crit Care Med. 2011 May; 12(3):e122-6. Polito A, Patorno E, Costello JM, Salvin JW, Emani SM, Rajagopal S, Laussen PC, Thiagarajan RR. PMID: 20625334.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    202. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA. 2010 Apr 14; 303(14):1401-9. Patorno E, Bohn RL, Wahl PM, Avorn J, Patrick AR, Liu J, Schneeweiss S. PMID: 20388896.
      View in: PubMed   Mentions:
    203. Work-related injuries in young workers: an Italian multicentric epidemiological survey. Ann Ist Super Sanita. 2006; 42(1):69-75. Aggazzotti G, Righi E, Patorno E, Fantuzzi G, Fabiani L, Giuliani AR, Grappasonni I, Petrelli F, Ricciardi W, La Torre G, Sciacca S, Angelillo I, Bianco A, Nobile C, Gregorio P, Lupi S, Perlangeli V, Bonazzi C, Laviola F, Triassi M, Iorfida E, Montegrosso S, Rivosecchi P, Serra MC, Adorisio E, Gramiccia A, Mura I, Castiglia P, Romano G, Poli A, Tardivo S. PMID: 16801728.
      View in: PubMed   Mentions:
    Elisabetta's Networks
    Concepts (450)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (3)
    People in Profiles who have published with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-18-gb39b692b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California